Alcon Current Ratio 2019-2023 | ALC
Current and historical current ratio for Alcon (ALC) from 2019 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Alcon current ratio for the three months ending December 31, 2023 was 2.28.
| Alcon Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $5.65B | $2.48B | 2.28 |
| 2023-09-30 | $5.55B | $2.51B | 2.21 |
| 2023-06-30 | $5.20B | $2.41B | 2.16 |
| 2023-03-31 | $5.33B | $2.60B | 2.05 |
| 2022-12-31 | $5.19B | $2.74B | 1.90 |
| 2022-09-30 | $5.16B | $2.33B | 2.21 |
| 2022-06-30 | $5.02B | $2.32B | 2.16 |
| 2022-03-31 | $4.89B | $2.25B | 2.18 |
| 2021-12-31 | $5.39B | $2.47B | 2.18 |
| 2021-09-30 | $5.29B | $2.38B | 2.23 |
| 2021-06-30 | $5.02B | $2.20B | 2.28 |
| 2021-03-31 | $4.97B | $1.97B | 2.53 |
| 2020-12-31 | $4.99B | $2.26B | 2.21 |
| 2020-09-30 | $4.78B | $2.09B | 2.29 |
| 2020-06-30 | $4.63B | $2.08B | 2.23 |
| 2020-03-31 | $4.13B | $2.13B | 1.93 |
| 2019-12-31 | $4.24B | $2.30B | 1.84 |
| 2019-09-30 | $4.22B | $2.25B | 1.88 |
| 2019-06-30 | $4.14B | $3.82B | 1.09 |
| 2019-03-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $40.439B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.369B | 27.43 |
| Intuitive Surgical (ISRG) | United States | $137.163B | 82.63 |
| Edwards Lifesciences (EW) | United States | $52.257B | 34.01 |
| DexCom (DXCM) | United States | $50.526B | 76.54 |
| IQVIA Holdings (IQV) | United States | $42.649B | 24.74 |
| IDEXX Laboratories (IDXX) | United States | $42.105B | 49.35 |
| STERIS (STE) | Ireland | $22.859B | 26.71 |
| Waters (WAT) | United States | $20.828B | 30.61 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.805B | 0.00 |
| Hologic (HOLX) | United States | $17.536B | 19.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.746B | 14.88 |
| ShockWave Medical (SWAV) | United States | $12.410B | 77.23 |
| Sysmex ADR (SSMXY) | Japan | $10.536B | 33.04 |
| Teleflex (TFX) | United States | $9.606B | 14.95 |
| Globus Medical (GMED) | United States | $8.761B | 25.68 |
| Penumbra (PEN) | United States | $8.229B | 93.51 |
| Masimo (MASI) | United States | $6.464B | 37.24 |
| Glaukos (GKOS) | United States | $5.564B | 0.00 |
| TransMedics (TMDX) | United States | $4.281B | 406.19 |
| Integer Holdings (ITGR) | United States | $3.818B | 23.07 |
| LivaNova (LIVN) | United Kingdom | $3.363B | 19.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.222B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.865B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.825B | 19.38 |
| Inari Medical (NARI) | United States | $2.544B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.453B | 20.75 |
| RxSight (RXST) | United States | $2.194B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.048B | 8.93 |
| Veracyte (VCYT) | United States | $1.634B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.611B | 0.00 |
| Artivion (AORT) | United States | $0.981B | 94.12 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.899B | 17.48 |
| OPKO Health (OPK) | United States | $0.892B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.830B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.741B | 0.00 |
| Paragon 28 (FNA) | United States | $0.643B | 0.00 |
| SiBone (SIBN) | United States | $0.632B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.626B | 21.25 |
| IRadimed (IRMD) | United States | $0.552B | 30.92 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.482B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.411B | 0.00 |
| Nevro (NVRO) | United States | $0.360B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.330B | 11.30 |
| Treace Medical Concepts (TMCI) | United States | $0.272B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.267B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.251B | 0.00 |
| NeuroPace (NPCE) | United States | $0.245B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.180B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.162B | 8.22 |
| Accuray (ARAY) | United States | $0.161B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.161B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.159B | 0.00 |
| CVRx (CVRX) | United States | $0.157B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.102B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 18.24 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Envoy Medical (COCH) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.060B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| InspireMD (NSPR) | Israel | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| LENSAR (LNSR) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.020B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |